Aion Therapeutic, formerly known as Osoyoos Cannabis Inc., has a joint-venture agreement with a private, vertically-integrated licensed producer under the Cannabis Act (Canada) to offer contract tolling extraction services to third-party businesses. Additionally, the Company recently acquired PCAI Pharma and its wholly-owned subsidiary AI Pharmaceuticals Jamaica Limited – a private corporation incorporated and operating under the laws of Jamaica.

The business of AI Pharmaceuticals Jamaica Limited involves, research and development, treatment, data mining and state-of-the-art artificial intelligence (machine learning) techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis (cannabinoids), psychedelic mushrooms (psilocybin), fungi (edible mushroom), natural psychedelic formulations (Ayahuasca), and other medicinal plants in a legal environment for this type of discovery.

Name Aion Therapeutic Inc
Symbol AION
Twitter N/A